Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR mHealth and uHealth (no longer under consideration since Jan 12, 2022)

Date Submitted: Jun 12, 2021
Open Peer Review Period: Jun 12, 2021 - Jun 21, 2021
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Assessing Quality Factors and User Preference of Drug Reference Apps in Taiwan: Systematic Search and Evaluation

  • Yu-Chun Chen; 
  • Wei-Wei Liao; 
  • Mei-Chin Su; 
  • Yen-Hsi Lin

ABSTRACT

Background:

Drug reference apps play various distinct and vital roles through the medication use process. A drug reference app that carried out comprehensive localized drug information would greatly improve the efficiency and quality of work for physicians, nurses, pharmacists, and patients.

Objective:

This current study aimed to describe a systematic and stepwise process to identify drug reference apps with localized drug information in Taiwan. Moreover, we assessed the quality of these apps by using a reliable quality assessment tool and further analyzing the influential factors for user ratings.

Methods:

A two-step algorithm (KESS) consisting of keyword growing and systematic search was proposed. Apps were divided into two groups: higher user ratings and lower user ratings. Seven independent reviewers were trained to evaluate these apps using Mobile App Rating Scale (MARS). A logistic regression model was fitted, and average marginal effects (AME) were calculated to identify the effects of factors for higher user ratings. A p-value< 0.05 was considered statistically significant.

Results:

A total of 23 drug reference apps in Taiwan had been identified and analyzed. Ten apps had higher user star ratings (>=4 stars), and 13 apps had lower user star ratings ( < 4 stars). These drug reference apps had acceptable quality with an average MARS score of 3.23. Apps with higher user star ratings had higher MARS scores than the lowers (engagement (2.70 v.s. 2.50, P= .005), functionality (3.85 v.s. 3.49, P= .003), aesthetics (3.39 v.s. 2.98, P < .001), and information (3.55 v.s. 3.25, P= .005)). The regression model showed five influential factors for higher user ratings (navigation, AME, 13.15%; performance, AME, 11.03%; visual appeal, AME, 10.87%; credibility, AME, 10.67%; quantity of information, AME, 10.42%).

Conclusions:

The proposed KESS algorithm could be a valuable and unbiased framework for systematic search for app. While the higher engagement, more functionality, better aesthetics, and more information associated with higher user ratings, there are five most influential factors, navigation, performance, visual appeal, credibility, and quantity of information among the four elements.


 Citation

Please cite as:

Chen YC, Liao WW, Su MC, Lin YH

Assessing Quality Factors and User Preference of Drug Reference Apps in Taiwan: Systematic Search and Evaluation

JMIR Preprints. 12/06/2021:31195

DOI: 10.2196/preprints.31195

URL: https://preprints.jmir.org/preprint/31195

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.